test

Nathalie Auber

@Sofinnova Investments, Inc.

Latest period2024 - Q3ReportedManaged Assets$1.26BTotal holdings58
Assets growth rate-34.51%Assets growth rate (2-Q avg)-13.66%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Sofinnova Investments, Inc.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 58 positions.

Assets under management

The assets under management (AUM) of Sofinnova Investments, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.26B in assets, with a quarterly growth rate of -34.51% and a 2-quarter average growth rate of -13.66%. The portfolio is managed by Nathalie Auber, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
INBXInhibrx Biosciences Inc
Recent Activity
Increased 15.71%
0.67%
$8.395M
536,068 shares@ $15.67 avg price
MRNSMarinus Pharmaceuticals Inc
Recent Activity
Increased 3.06%
0.62%
$7.72M
4.386M shares@ $1.77 avg price
CABACabaletta Bio Inc
Recent Activity
Increased 25.69%
0.58%
$7.24M
1.534M shares@ $4.73 avg price
ACHVAchieve Life Sciences Inc
Recent Activity
Increased 9.06%
0.57%
$7.177M
1.514M shares@ $4.75 avg price
PAHCPhibro Animal Health Corp
Recent Activity
Increased 0.5%
0.43%
$5.364M
238,184 shares@ $22.53 avg price
ERASErasca Inc
Recent Activity
Increased 8.43%
0.4%
$5.03M
1.843M shares@ $2.74 avg price
IRONDisc Medicine Inc
Recent Activity
Increased 41.35%
0.17%
$2.032M
41,352 shares@ $49.14 avg price
GPCRStructure Therapeutics Inc
Recent Activity
Increased 335.14%
0.14%
$1.703M
38,792 shares@ $43.9 avg price
RNAAvidity Biosciences Inc
Recent Activity
Increased 42.23%
0.12%
$1.4M
30,472 shares@ $45.94 avg price
ATXSAstria Therapeutics Inc
Recent Activity
Increased 41.11%
0.08%
$942,896
85,640 shares@ $11.01 avg price